Journal
BRAIN & DEVELOPMENT
Volume 28, Issue 10, Pages 663-667Publisher
ELSEVIER
DOI: 10.1016/j.braindev.2006.05.001
Keywords
Juvenile Alexander disease; novel GFAP mutation; thyrotropin releasing hormone (TRH) therapy; cerebellar ataxia
Categories
Ask authors/readers for more resources
Alexander disease is a rare disorder of the central nervous system caused by a de novo mutation in the glial fibrillary acidic protein (GFAP) gene. Unlike the much more common infantile form, the juvenile form is slowly progressive with bulbar, pyramidal and cerebellar signs. Herein, we report a 9-year old Japanese girl suffering from frequent vomiting, slurred speech and truncal ataxia. Juvenile Alexander disease was diagnosed by genetic analysis, which detected a novel GFAP mutation, D360V. We also describe our clinical success in treating this patient with thyrotropin releasing hormone (TRH). (c) 2006 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available